[1]强红梅,陈步强△,何 进,等.益气开秘方联合西药治疗便秘疗效及对患者血清5-HT、胃动素、血管活性肠肽水平的影响*[J].陕西中医,2020,(4):490-492.
 QIANG Hongmei,CHEN Buqiang,HE Jin,et al.The effect on serum 5-HT,MOT and VIP levels of Yiqi Kaimi recipe combined with itopride and lactulose in the treatment of patients with constipation[J].,2020,(4):490-492.
点击复制

益气开秘方联合西药治疗便秘疗效及对患者血清5-HT、胃动素、血管活性肠肽水平的影响*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2020年4期
页码:
490-492
栏目:
临床研究
出版日期:
2020-04-05

文章信息/Info

Title:
The effect on serum 5-HT,MOT and VIP levels of Yiqi Kaimi recipe combined with itopride and lactulose in the treatment of patients with constipation
文章编号:
DOI:10.3969/j.issn.10007369.2020.04.026
作者:
强红梅1陈步强2△何 进1张俊立1杨 梅1 赵 荣1郑惠之1唐军伟1
1.四川省南充市中心医院(南充 637000); 2.上海市第七人民医院(上海 200137)
Author(s):
QIANG HongmeiCHEN BuqiangHE Jinet al.
Central Hospital of Nanchong in Sichuan Province(Nanchong 637000)
关键词:
便秘 益气开秘方 伊托必利 乳果糖 血清5-羟色胺 胃动素 血管活性肠肽
Keywords:
Constipation Yiqi Kaiqi recipe Itopride Lactulose Curative effect Serum 5-HT MOT VIP
分类号:
R256.35
文献标志码:
A
摘要:
目的:研究益气开秘方联合伊托必利及乳果糖对气阴两虚型便秘患者疗效及血清5-羟色胺(5-HT)、胃动素(MOT)、血管活性肠肽(VIP)水平的影响。方法:选择气阴两虚型便秘患者168例。依据随机数字表法将其分成观察组和对照组各84例,对照组应用伊托必利和乳果糖。观察组加用益气开秘方。两组均治疗4周,对比两组疗效,临床症状评分,血清5-HT、MOT及VIP水平及并发症。结果:观察组总有效率97.62%,较对照组89.29%明显更高(P<0.05)。治疗后两组临床症状评分均明显低于治疗前,且观察组较对照组明显降低(P<0.05)。治疗后两组血清5-HT及VIP水平均明显低于治疗前,且观察组较对照组明显降低(P<0.05); 治疗后两组血清MOT水平明显高于治疗前,且观察组较对照组明显升高(P<0.05)。观察组并发症总发生率3.57%较对照组11.90%明显更低(P<0.05)。结论:应用益气开秘方联合伊托必利及乳果糖对气阴两虚型便秘患者的疗效较好,安全性较高,并可改善患者的血清5-HT、MOT及VIP水平。
Abstract:
Objective:To study the effect on 5-HT,MOT and vasoactive VIP levels of Yiqi Kaimi recipe combined with itopride and lactulose in the treatment of patients with constipation with deficiency of both Qi and Yin.Methods:168 patients with constipation with deficiency of both Qi and Yin were studied.According to the method of random number table,the patients were divided into observation group and control group,each had 84 cases.The control group were treated with itopride and lactulose.The observation group used Yiqi Kaimi recipe.Both groups were treated for 4 weeks,and then the curative effect,clinical symptom score,serum 5-HT,MOT and VIP levels,and complications were compared in two groups.Results:The total effective rate of the observation group was 97.62%,which was higher than the control group 89.29%(P<0.05).After treatment,the scores of clinical symptoms in both 2 groups were lower than before treatment,and the scores of clinical symptoms in the observation group were significantly lower than those in the control group(P <0.05).After treatment,the levels of serum 5-HT and VIP in the two groups were significantly lower than those before treatment,and the levels of serum MOT in the observation group were significantly lower than those in the control group after treatment,and the levels of serum MOT in the observation group were significantly higher than those in the control group after treatment.The total incidence of complications in the observation group was 3.57%,which was lower than the control group 11.90%(P<0.05).Conclusion:The application of Yiqi Kaimi recipe combined with itopride and lactulose is effective and safe in the treatment of constipation with deficiency of both Qi and Yin,and can improve the serum levels of 5-HT,MOT and VIP.

参考文献/References:

[1] 万顺梅,刘福侠,万芙蓉,等.乳果糖氢呼气试验评估便秘型肠易激综合征的临床价值[J].中国临床研究,2018,31(7):947-949.
[2] 林仁敬,谭 蕊.白术七物颗粒对气阴两虚型结肠慢传输型便秘大鼠结肠组织血管活性肠肽及P物质的影响[J].中国全科医学,2016,19(3):336-339.
[3] 张声生.慢性便秘中医诊疗共识意见[J].北京中医药,2011,30(1):3-7.
[4] 曹 军,龙再菊.伊托必利治疗慢性便秘患者的临床疗效[J].中国药物经济学,2018,13(3):99-101.
[5] 柴 晟,金 瑛,周 彬,等.穴位埋线联合乳果糖治疗肠易激综合征便秘型35例临床研究[J].江苏中医药,2019,51(8):63-65.
[6] 余文美,王建民,方笑丽,等.益气健脾通便方联合乳果糖治疗慢传输型便秘肺脾气虚证临床观察[J].安徽中医药大学学报,2019,38(2):16-19.
[7] 周 峰,张 旗,张永安,等.益气养阴方治疗慢性功能性便秘(气阴两虚证)的临床研究[J].河北中医,2017,39(11):1646-1649.
[8] 任 欣.“增液温下方”联合常规疗法治疗老年慢性功能性便秘100例临床研究[J].江苏中医药,2019,51(7):36-39.
[9] 郭 伟,朱凤池,杨 静,等.聚乙二醇4000散联合乳果糖治疗妊娠便秘的临床疗效[J].中国计划生育学杂志,2019,27(2):189-191.
[10] 魏 妮,梁靖华,孙林梅,等.益气养阴汤与莫沙比利治疗老年气阴两虚型慢性便秘患者疗效对比[J].环球中医药,2017,10(1):94-96.
[11] 李 锋,李跃川,李泽民,等.乳酸菌联合乳果糖治疗老年功能性便秘的远期效果[J].西南国防医药,2018,28(10):956-958.
[12] 温 泉.氟哌噻吨美利曲辛联合伊托必利治疗便秘型肠易激综合征的疗效[J].江苏医药,2017,43(22):1600-1602.
[13] 李秀锋.乳果糖与双歧杆菌四联活菌治疗老年人功能性便秘的效果评价[J].中国药物与临床,2019,19(8):1294-1295.
[14] 郭 萍,王丽君.莫沙必利与双歧杆菌分别联合聚乙二醇散治疗功能性便秘的疗效及安全性分析[J].陕西医学杂志,2019,48(4):508-511.
[15] 封若雨,朱新宇,葛少钦,等.老年性便秘的中医辨证论治[J].陕西中医,2019,40(7):931-933.

相似文献/References:

[1]朱 竞,刘远成,唐 昆,等.针灸联合生物反馈治疗盆底失弛缓型便秘疗效观察*[J].陕西中医,2020,(7):976.[doi:DOI:10.3969/j.issn.10007369.2020.07.042]
 ZHU Jing,LIU Yuancheng,TANG Kun,et al.Evaluation for efficacy of biofeedback combining acupunture therapy in patients with constipation caused by pelvic floor anismus[J].,2020,(4):976.[doi:DOI:10.3969/j.issn.10007369.2020.07.042]
[2]石 雷,张立新,李立华,等.基于“肺与大肠相表里”理论探讨加味桔梗汤从肺论治骨科术后气滞型便秘临床研究[J].陕西中医,2021,(1):81.[doi:DOI:10.3969/j.issn.1000-7369.2020.01.021]
[3]王彩霞,韦 林,李春玲,等.补气温阳法治疗老年性胸腰椎骨折中后期便秘临床研究[J].陕西中医,2022,(2):211.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.017]
 WANG Caixia,WEI Lin,LI Chunling,et al.Clinical effects of the method of invigorating qi and warming yang in the treatment of senile thoracolumbar fracture with constipation in middle and late stages[J].,2022,(4):211.[doi:DOI:10.3969/j.issn.1000-7369.2022.02.017]
[4]范小春,许仕坤,周南邻,等.补气温阳通便散治疗老年陈旧性胸腰椎骨折患者椎体成形术术后便秘临床研究[J].陕西中医,2022,(11):1567.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.018]
 FAN Xiaochun,XU Shikun,ZHOU Nanlin,et al.Buqi Wenyang Tongbian powder in treating constipation after PVP in elderly patients with obsolete thoracolumbar vertebral fractures[J].,2022,(4):1567.[doi:DOI:10.3969/j.issn.1000-7369.2022.11.018]
[5]李 芳,黄 超,周 琦,等.调脾安肠方联合虎符铜砭刮痧治疗老年糖尿病胃轻瘫所致便秘临床疗效[J].陕西中医,2024,(8):1130.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.027]
 LI Fang,HUANG Chao,ZHOU Qi,et al.The clinical efficacy of Tiaopi Anchang recipe combined with Hufu Tongbian Guasha in the treatment of constipation caused by diabetic gastroparesis in the elderly[J].,2024,(4):1130.[doi:DOI:10.3969/j.issn.1000-7369.2024.08.027]
[6]刘安琪,唐学贵.枳实对慢传输型便秘的药理作用及配伍应用研究现状[J].陕西中医,2025,46(2):277.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.028]
 LIU Anqi,TANG Xuegui.Current research on the pharmacological effect of Citrus aurantium on slow-transit constipation and clinical compatibility[J].,2025,46(4):277.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.028]

备注/Memo

备注/Memo:
*国家名老中医医案研究中心立项项目(YAZX19-Y-09);上海市浦东新区海派中医流放浦东基地建设项目(PDZY-2018-0702)
更新日期/Last Update: 2020-04-13